The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 3 , Pages 608-612 , September 2009

The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction

  • Brechtje A. Grotenhuis, MD

      Affiliations

    • Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationAddress for reprints: Brechtje A. Grotenhuis, MD, Erasmus Medical Center, Department of Surgery, PO Box 2040, 3000 CA Rotterdam, The Netherlands.
  • ,
  • Bas P.L. Wijnhoven, MD, PhD

      Affiliations

    • Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Ronald van Marion

      Affiliations

    • Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Herman van Dekken, MD, PhD

      Affiliations

    • Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Wim C. Hop, PhD

      Affiliations

    • Department of Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Hugo W. Tilanus, MD, PhD

      Affiliations

    • Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • J. Jan B. van Lanschot, MD, PhD

      Affiliations

    • Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
  • ,
  • Casper H.J. van Eijck, MD, PhD

      Affiliations

    • Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands

Received 17 July 2008 ,Revised 17 October 2008 ,Accepted 27 November 2008.

References 

  1. Pera M, Materola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol. 2005;92:151–159
  2. Marsman WA, Tytgat GN, Ten Kate FJ, Van Lanschot JJ. Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction. J Surg Oncol. 2005;92:160–168
  3. Hölscher AH, Bollschweiler E, Bumm R, Bartels H, Hofler H, Siewert JR. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery. 1995;118:845–855
  4. Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000;232:353–361
  5. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the US. The importance of tumor length and lymph node status. Cancer. 2002;95:1434–1443
  6. Hulscher JB, Van Sandick JW, De Boer AG, Wijnhoven B, Tijssen J, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662–1669
  7. D'Journo XB, Doddoli C, Michelet P, Loundou A, Trousse D, Giudicelli R, et al. Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy?. Eur J Cardiothorac Surg. 2005;27:697–704
  8. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–400
  9. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345–2350
  10. Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337:1188–1194
  11. Waterman TA, Hagen JA, Peters JH, DeMeester SR, Taylor CR, DeMeester TR. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg. 2004;78:1161–1169
  12. Heeren PA, Kelder W, Blondeel I, Van Westreenen HL, Hollema H, Plukker JT. Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction. Eur J Surg Oncol. 2005;31:270–276
  13. Sobin L, Wittekind C. UICC TNM Classification of Malignant Tumors. 6th ed. New York: John Wiley & Sons, Inc; 2002;
  14. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells. Clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer. 2003;98:2740–2741
  15. Makin CA, Bobrow LG, Bodmer WF. Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol. 1984;37:975–983
  16. Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a “sentinel node” in cancer of the parotid. Cancer. 1960;13:77–78
  17. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast. Cancer. 2002;94:2542–2551
  18. Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–351
  19. Kosaka T, Ueshige N, Sugaya J, Nakano Y, Akiyama T, Tomita F, et al. Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg Today. 1999;29:695–700
  20. Schlag PM, Bembenek A, Schulze T. Sentinel node biopsy in gastrointestinal-tract cancer. Review. Eur J Cancer. 2004;40:2022–2032
  21. Tangoku A, Seike J, Nakano K, Nagao T, Honda J, Yoshida T, et al. Current status of sentinel lymph node navigation surgery in breast and gastrointestinal tract. Review. J Med Invest. 2007;54:1–18
  22. Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, MacDonald JS, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol. 2003;10:213–218
  23. Rice TW. Superficial oesophageal carcinoma: is there a need for three-field lymphadenectomy?. Lancet. 1999;354:792–794
  24. Hosch SB, Stoecklein NH, Pichlmeier U, Rehders A, Scheunemann P, Niendorf A, et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol. 2001;19:1970–1975
  25. Dresner SM, Lamb PJ, Bennett MK, Hayes N, Griffin SM. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery. 2001;129:103–109
  26. Feith M, Stein HJ, Siewert JR. Pattern of lymphatic spread of Barrett's cancer. World J Surg. 2003;27:1052–1057
  27. Cense HA, Van Eijck CH, Tilanus HW. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract Res Clin Gastroenterol. 2006;20:893–906
  28. Mariani G, Moresco L, Viale G, Villa G, Bagnasco M, Canavese G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001;42:1198–1215
  29. Lamb PJ, Griffin SM, Burt AD, Lloyd J, Karat D, Hayes N. Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg. 2005;92:60–67
  30. Burian M, Stein HJ, Sendler A, Piert M, Nahrig J, Feith M, et al. Sentinel node detection in Barrett's and cardia cancer. Ann Surg Oncol. 2004;11:255S–258

PII: S0022-5223(09)00094-4

doi: 10.1016/j.jtcvs.2008.11.061

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 3 , Pages 608-612 , September 2009